Point-of-care testing for CXCL13 in Lyme neuroborreliosis

: Annukka Pietikäinen, Jarmo Oksi, Jukka Hytönen

Publisher: Elsevier Inc.

: 2018

: Diagnostic Microbiology and Infectious Disease

: 91

: 3

: 226

: 228

: 3

: 0732-8893

: 1879-0070

DOI: https://doi.org/10.1016/j.diagmicrobio.2018.02.013

Cerebrospinal fluid chemokine (C-X-C motif)
ligand 13 (CXCL13) is a marker for Lyme neuroborreliosis (LNB). CXCL13 lateral
flow immunoassay (LFA) was compared with CXCL13 ELISA. CXCL13 LFA results
correlated strongly with CXCL13 ELISA results. CXCL13 LFA is a rapid and
easy-to-perform test, which is suitable for routine point-of-care diagnostics
of suspected LNB patients.